2nd Quarter - Report

FEROX STRATEGIES for VIATRIS INC

Firm
Client
Income
$70,000
Expenses
—

What was lobbied

3 issue areas, each in the filer's own words, with who lobbied on it and where.

Pharmacy PHA

Policy and oversight related to the generic pharmaceutical industry. Issues related to drug pricing. Issues related to FDA generic drug approval process. General issues related to Agriculture Appropriations.

LobbyistCovered position, as disclosed
CRISTINA ANTELO —
DEBRA DIXON —
MICHAEL TAGGART —
MARK WILLIAMS —

Contacted: HOUSE OF REPRESENTATIVES; Health & Human Services, Dept of (HHS); SENATE

Foreign Relations FOR

Issues related to PEPFAR.

LobbyistCovered position, as disclosed
CRISTINA ANTELO —
MICHAEL TAGGART —
MARK WILLIAMS —

Contacted: SENATE; HOUSE OF REPRESENTATIVES

Trade (domestic/foreign) TRD

ITrade issues related to generic medicines.

LobbyistCovered position, as disclosed
MARK WILLIAMS —

Contacted: HOUSE OF REPRESENTATIVES; SENATE; Commerce, Dept of (DOC); U.S. Trade Representative (USTR); Executive Office of the President (EOP)

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.